Mia's Feed
Medical News & Research

Recall of Zicam and Orajel Swabs Due to Fungal Contamination Risk

Recall of Zicam and Orajel Swabs Due to Fungal Contamination Risk

Share this article

Certain Zicam and Orajel nasal and teething swabs are being recalled due to potential fungal contamination, posing health risks especially for children and immunocompromised individuals.

2 min read

In a recent safety alert, U.S. health authorities have announced the nationwide recall of certain nasal and teething swabs manufactured by Church & Dwight Co., Inc., including Zicam Cold Remedy Nasal Swabs, Zicam Nasal AllClear Swabs, and Orajel Baby Teething Swabs. The recall was initiated after the manufacturer identified potential fungal contamination in the cotton components of these products during routine testing.

Consumers are advised to immediately stop using these recalled products, as fungal contamination can pose serious health risks. The infection risk is particularly high for children, individuals with compromised immune systems, or those with existing health conditions. In rare cases, fungal exposure from contaminated swabs can lead to severe infections, including potentially life-threatening blood infections.

The recall covers all lot numbers of the specified products, but other Zicam and Orajel items not listed remain safe. The FDA emphasized that no reported illnesses or injuries have been linked to these products as of now.

Consumers who have purchased affected swabs should visit the official recall website at churchdwightrecall.com or contact the company at (800) 981-4710 for a full refund. The FDA continues to monitor the situation to ensure consumer safety.

This recall highlights the importance of inspecting health products for manufacturing issues and adhering to safety advisories. While most products are safe, fungi-contaminated swabs can cause serious infections, underscoring the need for caution and prompt action when safety warnings are issued.

For further details, the full recall notice is available on the FDA website.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Why New Zealand’s Limited Access to the Cochrane Library Raises Concerns

New Zealand is reducing access to the Cochrane Library, a vital source of independent health evidence, raising concerns about health equity and informed decision-making. Learn about the implications of this policy change.

Breakthrough in Lung Transplant Technology: Portable Preservation System Enhances Outcomes for Extended Criteria Donor Lungs

Baylor College of Medicine confirms that the portable Organ Care System improves lung transplant outcomes from extended criteria donors, expanding the donor pool and benefitting recipients long-term.

High Undiagnosed Rates of Autism in Middle-Aged and Older Adults in the UK Highlight Critical Gaps

A groundbreaking review from King's College London reveals that nearly 90% of autistic adults over 40 in the UK are undiagnosed, exposing critical gaps in healthcare and support for aging populations.